Inhaled Selective Pulmonary Vasodilators for Advanced Heart Failure Therapies and Lung Transplantation Outcomes

PHASE4CompletedINTERVENTIONAL

Enrollment

519

Participants

Timeline

Start Date

May 4, 2017

Primary Completion Date

October 5, 2020

Study Completion Date

September 5, 2021

Conditions

Heart Transplant SurgeryLung Transplant Surgery

Interventions

DRUG

iNO

Subject will receive inhaled Nitric Oxide in this intervention

DRUG

iEPO

Subject will receive inhaled Epoprostrenol in this intervention

Trial Locations (1)

Duke Health, Durham